Skip to content
Disclosery

Bain Capital Life Sciences Investors, LLC: EVR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bain Capital Life Sciences Investors, LLC on EVR, newest first. How the timeline and the estimate are built.

Bain Capital Life Sciences Investors, LLC held 0 EVR shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -463,147 shares

    13F-HR 0001768111-26-000002 filed by Bain Capital Public Equity Management II, LLC
    Filed (acceptance time not in the bulk data set), ingested

    • Bain Capital Public Equity Management II, LLC: 0 shares
    • Bain Capital Public Equity, LP: 0 shares

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 463,147 shares
    Change vs previous 13F +198,540 shares

    6.8% of the 13F portfolio, value $156,228,746.

    13F-HR 0001768111-25-000017 filed by Bain Capital Public Equity Management II, LLC
    Filed (acceptance time not in the bulk data set), ingested

    • Bain Capital Public Equity Management II, LLC: 434,209 shares
    • Bain Capital Public Equity, LP: 28,938 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 264,607 shares
    Change vs previous 13F not available

    3.16% of the 13F portfolio, value $71,449,182.

    13F-HR 0001768111-25-000011 filed by Bain Capital Public Equity Management II, LLC
    Filed (acceptance time not in the bulk data set), ingested

    • Bain Capital Public Equity Management II, LLC: 247,444 shares
    • Bain Capital Public Equity, LP: 17,163 shares

    Acceptance time not in the bulk data set (spec §4.2).